Literature DB >> 33753986

Identification of hub genes-based predictive model in hepatocellular carcinoma by robust rank aggregation and regression analysis.

Di Wu1, Yun Pan2, Xueyong Zheng1.   

Abstract

Background: Though various hub genes for HCC have been identified in decades, the limited sample size, inconsistent bioinformatic analysis methods and lacking evaluation in validation cohorts would make the results less reliable, novel biomarkers and risk model for HCC prognosis are still urgently desired.
Methods: The Robust Rank Aggression method was applied to integrate 12 HCC microarray datasets to screen for robustly and stably differentially expressed candidates. The Least Absolute Shrinkage and Selection Operator regression and multivariate Cox regression analysis were performed to construct a six hub genes-based prognostic model, which was further verified in matched tumor and non-tumor hepatic samples and two independent validation cohorts.
Results: Six hub genes for HCC were identified including CD163, EHHADH, KIAA0101, SLC16A2, SPP1 and THBS4. The risk score according to hub genes-based prognostic model could be an independent predictive factor for HCC. Quantitative real-time polymerase chain reaction results showed significant difference in expression level between tumor and non-tumor hepatic tissues. Prognostic value of risk model has been verified in TCGA-HCC and GSE76240 datasets. Biological function analysis revealed these hub genes were closely associated with tumorigenesis processes.
Conclusion: A novel six hub genes predictive risk model for HCC has been established based on multiple datasets analyses, providing novel features for the prediction of HCC patients' outcome. © The author(s).

Entities:  

Keywords:  bioinformatic analysis; hepatocellular carcinoma; hub gene; prognostic risk model; regression analysis; validation dataset

Year:  2021        PMID: 33753986      PMCID: PMC7974519          DOI: 10.7150/jca.52089

Source DB:  PubMed          Journal:  J Cancer        ISSN: 1837-9664            Impact factor:   4.207


  23 in total

1.  clusterProfiler: an R package for comparing biological themes among gene clusters.

Authors:  Guangchuang Yu; Li-Gen Wang; Yanyan Han; Qing-Yu He
Journal:  OMICS       Date:  2012-03-28

Review 2.  Screening for hepatocellular carcinoma.

Authors:  J Collier; M Sherman
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

3.  RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.

Authors:  Mengnuo Chen; Lai Wei; Cheuk-Ting Law; Felice Ho-Ching Tsang; Jialing Shen; Carol Lai-Hung Cheng; Long-Hin Tsang; Daniel Wai-Hung Ho; David Kung-Chun Chiu; Joyce Man-Fong Lee; Carmen Chak-Lui Wong; Irene Oi-Lin Ng; Chun-Ming Wong
Journal:  Hepatology       Date:  2018-04-19       Impact factor: 17.425

4.  Genome-wide screening diagnostic biomarkers and the construction of prognostic model of hepatocellular carcinoma.

Authors:  Furong Liu; Zhibin Liao; Jia Song; Chaoyi Yuan; Yachong Liu; Hongwei Zhang; Yonglong Pan; Zhanguo Zhang; Bixiang Zhang
Journal:  J Cell Biochem       Date:  2019-11-06       Impact factor: 4.429

5.  Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review.

Authors:  Agostino Colli; Mirella Fraquelli; Giovanni Casazza; Sara Massironi; Alice Colucci; Dario Conte; Piergiorgio Duca
Journal:  Am J Gastroenterol       Date:  2006-03       Impact factor: 10.864

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

7.  Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation.

Authors:  Lijuan Liu; Xiaobei Chen; Shuixiang Xie; Chuanjie Zhang; Zhenpeng Qiu; Fan Zhu
Journal:  Hepatology       Date:  2012-10-14       Impact factor: 17.425

Review 8.  Biology and significance of alpha-fetoprotein in hepatocellular carcinoma.

Authors:  Peter R Galle; Friedrich Foerster; Masatoshi Kudo; Stephen L Chan; Josep M Llovet; Shukui Qin; William R Schelman; Sudhakar Chintharlapalli; Paolo B Abada; Morris Sherman; Andrew X Zhu
Journal:  Liver Int       Date:  2019-09-11       Impact factor: 5.828

9.  Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma.

Authors:  Yujia Zheng; Yulin Liu; Songfeng Zhao; Zhetian Zheng; Chunyi Shen; Li An; Yongliang Yuan
Journal:  Cancer Manag Res       Date:  2018-11-21       Impact factor: 3.989

10.  Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data.

Authors:  Hua-Yu Wu; Zhi-Gang Peng; Rong-Quan He; Bin Luo; Jie Ma; Xiao-Hua Hu; Yi-Wu Dang; Gang Chen; Shang-Ling Pan
Journal:  Int J Oncol       Date:  2019-06-27       Impact factor: 5.650

View more
  1 in total

1.  Hub genes associated with immune cell infiltration in breast cancer, identified through bioinformatic analyses of multiple datasets.

Authors:  Huanyu Zhao; Ruoyu Dang; Yipan Zhu; Baijian Qu; Yasra Sayyed; Ying Wen; Xicheng Liu; Jianping Lin; Luyuan Li
Journal:  Cancer Biol Med       Date:  2022-07-13       Impact factor: 5.347

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.